Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer

Prostate cancer is the most dominant male malignancy worldwide. The clinical presentation of prostate cancer ranges from localized indolent to rapidly progressing lethal metastatic disease. Despite a decline in death rate over the past years, with the advent of early diagnosis and new treatment opti...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Eshwari Dathathri, Khrystany T. Isebia, Fikri Abali, Martijn P. Lolkema, John W. M. Martens, Leon W. M. M. Terstappen, Ruchi Bansal
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2022-05-01
Serie:Frontiers in Oncology
Soggetti:
Metastatic prostate cancer
circulating biomarkers
circulating tumor cells (CTC)
secretory factors
extracellular vesicles (EVs)
prognostic biomarkers
Accesso online:https://www.frontiersin.org/articles/10.3389/fonc.2022.863472/full
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi